drugset / Trial / NCT00446368
Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer
NaSingle-groupOpen-labelTreatment
Summary
Patients with metastatic renal cell cancer will be enrolled to receive RAD001 to determine whether the use of RAD001 will result in an improvement in the time to tumor progression.
Timeline
- Start
- 2005-05
- Primary completion
- 2008-09
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | 10 mg | Oral |